• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Mentice AB (STO: MNTC) Completes the Acquisition of ANKYRAS

Share:

July 5, 2022

Mentice AB (STO: MNTC) (“Mentice”) Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on 9th June 2022, now has been completed.

The information was submitted for release, through the request of the contact person below, at 21:20 CEST on 30 June 2022.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Uniphore CEO Talks Call Centers & Why Contact Tracing is FailingUniphore CEO Talks Call Centers & Why Contact Tracing is Failing
  • Cedar, athenahealth Partner to Bring Personalized, Digital-First Financial Experience to PatientsCedar, athenahealth Partner to Bring Personalized, Digital-First Financial Experience to Patients
  • Halma Acquires AI-Powered Perinatal Platform PeriGen for $58MHalma Acquires AI-Powered Perinatal Platform PeriGen for $58M
  • Influenza B Infection Market in 2021 – Detailed Analysis ReportInfluenza B Infection Market in 2021 – Detailed Analysis Report
  • Saudi’s Abdul Latif Jameel Health Launches “Pioneering” Heart Surgery Procedure in the GCCSaudi’s Abdul Latif Jameel Health Launches “Pioneering” Heart Surgery Procedure in the GCC
  • Cerebral Inc. Lands $300M; AI-Backed Clinical Assistant Robin Rakes in $50MCerebral Inc. Lands $300M; AI-Backed Clinical Assistant Robin Rakes in $50M
  • SPACs Offer Efficiency and Flexibility for Biopharma Startups. Will the Trend Last?SPACs Offer Efficiency and Flexibility for Biopharma Startups. Will the Trend Last?
  • Aktana Lands $20M For AI-Enabled Decision Support For Life SciencesAktana Lands $20M For AI-Enabled Decision Support For Life Sciences

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications